{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:04:58Z","timestamp":1783595098305,"version":"3.55.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T00:00:00Z","timestamp":1313107200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023136","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T20:51:11Z","timestamp":1313182271000},"page":"e23136","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators"],"prefix":"10.1371","volume":"6","author":[{"given":"Charlene S.","family":"Dezzutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Louissaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Kalyoussef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Merna","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hladik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvi","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mellors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy C.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Q Abdool Karim","year":"2010","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.","volume":"194","author":"P Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.","volume":"372","author":"S Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.","volume":"376","author":"S McCormack","year":"2010","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.","volume":"25","author":"SS Abdool Karim","year":"2011","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri2302","article-title":"Setting the stage: host invasion by HIV.","volume":"8","author":"F Hladik","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/OLQ.0b013e3181994191","article-title":"Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety.","volume":"36","author":"JE Cummins Jr","year":"2009","journal-title":"Sex Transm Dis"},{"key":"ref10","article-title":"Report on global AIDS epidemic.","year":"2010"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","article-title":"Innate and adaptive immunity in female genital tract: cellular responses and interactions.","volume":"206","author":"CR Wira","year":"2005","journal-title":"Immunol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0897.2010.00842.x","article-title":"Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens.","volume":"63","author":"CR Wira","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.","volume":"35","author":"L Corey","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/511278","article-title":"Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.","volume":"195","author":"RS McClelland","year":"2007","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e10094","DOI":"10.1371\/journal.pone.0010094","article-title":"Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.","volume":"5","author":"KK Smith-McCune","year":"2010","journal-title":"PLoS ONE"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.","volume":"105","author":"BF Keele","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000274","DOI":"10.1371\/journal.ppat.1000274","article-title":"Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.","volume":"5","author":"RE Haaland","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e11366","DOI":"10.1371\/journal.pone.0011366","article-title":"Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.","volume":"5","author":"M Ghosh","year":"2010","journal-title":"PLoS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0b013e328013d9b5","article-title":"PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.","volume":"21","author":"MJ Keller","year":"2007","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0897.2009.00768.x","article-title":"Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.","volume":"63","author":"GF Shust","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.4049\/jimmunol.175.11.7560","article-title":"Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.","volume":"175","author":"N Venkataraman","year":"2005","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1089\/aid.2006.22.788","article-title":"Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.","volume":"22","author":"JE Cummins","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/aid.2010.0129","article-title":"Cervicovaginal Shedding of HIV Type 1 Is Related to Genital Tract Inflammation Independent of Changes in Vaginal Microbiota.","volume":"27","author":"C Mitchell","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/erv.10.21","article-title":"Assessment of mucosal immunity to HIV-1.","volume":"9","author":"V Jespers","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0952-7915(01)00303-X","article-title":"Defensins of vertebrate animals.","volume":"14","author":"RI Lehrer","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CDLI.2.1.57-61.1995","article-title":"Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays.","volume":"2","author":"L Belec","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":"Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.","volume":"22","author":"J Atashili","year":"2008","journal-title":"AIDS"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1128\/JCM.43.10.5295-5297.2005","article-title":"Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.","volume":"43","author":"KG Ghanem","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2005.11.002","article-title":"Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance and adequacy of Papanicolaou smear.","volume":"19","author":"KG Ghanem","year":"2006","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.","volume":"29","author":"RP Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1095\/biolreprod60.2.508","article-title":"Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells.","volume":"60","author":"RN Fichorova","year":"1999","journal-title":"Biol Reprod"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0897.2004.00248.x","article-title":"Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection.","volume":"53","author":"CR Wira","year":"2005","journal-title":"Am J Reprod Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1128\/JCM.44.3.1084-1086.2006","article-title":"Use of flocked swabs and a universal transport medium to enhance molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae.","volume":"44","author":"M Chernesky","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jviromet.2009.08.011","article-title":"Detection of high risk HPV and Chlamydia trachomatis in vaginal and cervical samples collected with flocked nylon and wrapped rayon dual swabs transported in dry tubes.","volume":"162","author":"T Krech","year":"2009","journal-title":"J Virol Methods"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/JCM.00991-10","article-title":"Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women.","volume":"49","author":"C Mitchell","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.1128\/JVI.01899-08","article-title":"Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.","volume":"83","author":"SK Lai","year":"2009","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.","volume":"104","author":"SK Lai","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/IAI.66.9.4163-4168.1998","article-title":"The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions.","volume":"66","author":"A Berneman","year":"1998","journal-title":"Infection & Immunity"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00002030-200104130-00018","article-title":"Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding.","volume":"15","author":"N Chomont","year":"2001","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1067\/mob.2000.107383","article-title":"Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections.","volume":"183","author":"DL Draper","year":"2000","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"ref41","first-page":"527","article-title":"Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial.","volume":"102","author":"MH Yudin","year":"2003","journal-title":"Obstet Gynecol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/CVI.00386-06","article-title":"Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.","volume":"14","author":"RM Novak","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1128\/IAI.00524-06","article-title":"Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis.","volume":"74","author":"EV Valore","year":"2006","journal-title":"Infect Immun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e16475","DOI":"10.1371\/journal.pone.0016475","article-title":"A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel.","volume":"6","author":"MJ Keller","year":"2011","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e8781","DOI":"10.1371\/journal.pone.0008781","article-title":"Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials.","volume":"5","author":"MJ Keller","year":"2010","journal-title":"PLoS ONE"},{"key":"ref46","article-title":"The Microbicide Development Strategy","year":"2006"}],"updated-by":[{"DOI":"10.1371\/annotation\/7824df54-632a-48d6-bfbe-42d069d40c6e","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T07:10:11Z","timestamp":1592809811000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023136"}},"subtitle":[],"editor":[{"given":"Kathleen A.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,12]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023136","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/7824df54-632a-48d6-bfbe-42d069d40c6e","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,12]]}}}